Eli Lilly launches program to boost employer coverage of obesity drugs
Eli Lilly on Thursday launched a new program designed to help more employers cover obesity drugs in the…
Why Novo Nordisk’s Ireland expansion is key to fighting off Eli Lilly
Novo Nordisk is investing 432 million euros ($506 million) in a facility in Ireland as it expands its…
Eli Lilly launches Zepbound obesity drug pen with one month of doses
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York on March…
Hims & Hers Health to acquire Australia’s Eucalyptus for up to $1.15 billion
Hims & Hers Health said on Thursday it will acquire Australian digital health company Eucalyptus in a deal…
Taking the new Wegovy pill every day is really complicated. Will patients stick with it?
Last Updated: Feb. 11, 2026 at 8:59 a.m. ETFirst Published: Feb. 10, 2026 at 3:48 p.m. ET Patients are thrilled…
HIMS Dips 55.8% in 3 Months: Should You Still Hold the Stock or Sell?
Hims & Hers Health, Inc.’s HIMS investors have been experiencing some short-term losses lately. The San Francisco, CA-based…
Takaichi and the AI trade in focus this week
Japan’s Prime Minister Sanae Takaichi, leader of the ruling Liberal Democratic Party (LDP), speaks during a press conference…
5 things to know before the stock market opens Monday
This is CNBC’s Morning Squawk newsletter. Subscribe here to receive future editions in your inbox. Happy Monday. Congratulations to the…
Hims & Hers falls 8% after Novo’s legal threat. Here’s the latest
Rafael Henrique | SOPA Images | AP The stock of Hims & Hers dropped in premarket trading early…
Hims & Hers announces Wegovy pill copy; Novo Nordisk vows legal action
The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, Copenhagen, Denmark,…
What a rate cut means for stocks, plus a bullish call on AI spending
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just…
Researchers move closer to a universal cancer vaccine
Wildpixel | Istock | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter,…